DolCas-Tenshi Bioceuticals

DolCas-Tenshi Bioceuticals is a strategic joint venture between US-based DolCas Biotech and India-based Tenshi Kaizen, specializing in the development and commercialization of science-backed natural ingredients. The company focuses on bridging the gap between traditional herbal medicine and modern pharmaceutical standards through rigorous clinical validation and advanced delivery technologies. Their portfolio features high-potency, bioavailable extracts such as BCM-95 curcumin, Ginfort ginger, and Bergacyn, which target indications ranging from chronic inflammation to metabolic and digestive health. By leveraging global manufacturing capabilities and intellectual property, DolCas-Tenshi provides the nutraceutical and functional food industries with premium, clinically-studied raw materials. The company is headquartered in New Jersey and maintains a strong research and development presence in India.